Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: J Matern Fetal Neonatal Med. 2020 Jan 13;35(1):58–65. doi: 10.1080/14767058.2020.1711728

Table 5.

Linear regression models for the relationship between maternal race and ethnicity and percent of elevated glucoses when pharmacotherapy was initiated after excluding 44 women diagnosed with GDM in the first trimester

Percent of abnormal blood glucose values prior to pharmacotherapy initiation Adjusted linear regression coefficient (95% CI) p-value
Race
 Non-Hispanic White Ref
 Non-Hispanic Black 18.71 (11.63 – 25.79) <0.001
 Hispanic 11.64 (3.26 – 20.03) 0.007
 Other 8.53 (0.92 – 16.14) 0.028
Maternal age −0.14 (−0.64 – 0.35) 0.568
Body mass index in early pregnancy(kg/m2) 0.47 (0.18 – 0.76) 0.001
Marital Status
 Single Ref
 Married −1.31 (−7.30 – 4.68) 0.667
 Divorced 7.27 (−6.97 – 21.51) 0.316
Insurance Status
 Private Ref
 Public 7.26 (1.00 – 13.53) 0.023
 None −4.82 (−12.95 – 3.30) 0.244
Preexisting hypertension
 No Ref
 Yes −2.74 (−15.50 – 10.02) 0.673
Gestational age at GDM diagnosis (wks) 0.19 (−0.48 – 0.86) 0.577

Bold indicates significant p-value